Direct-Acting Oral Anticoagulants (DOAC) Score
Código: 10551 · direct_acting_oral_anticoagulants_doac_score
Predicts bleeding risk in patients with atrial fibrillation on DOAC.
Ver respuesta cruda
Referencias
Original/Primary Reference
- Aggarwal R, Ruff CT, Virdone S, et al. Development and validation of the doac score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants. Circulation. 2023;148(12):936-946. ↗
Other References
- Ezekowitz MD, Kamareddine M. Filling an important knowledge gap: the doac score. Circulation. 2023;148(12):947-949. ↗
- Zeng S, Zhu W, Guo S, Hong H. Predictive performance of HAS-BLED, ORBIT, ABC, and DOAC scores for major bleeding in atrial fibrillation patients on DOACs. Eur J Intern Med. Published online July 4, 2024:S0953-6205(24)00282-6. ↗
Validation
- Aggarwal R, Ruff CT, Virdone S, et al. Development and validation of the doac score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants. Circulation. 2023;148(12):936-946. ↗
- Mei DA, Imberti JF, Bonini N, et al. Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry. European Journal of Internal Medicine. Published online July 2024:S0953620524002772. ↗
- Abu-Assi E, Lizancos Castro A, Cespón-Fernández M, González-Bermúdez I, Raposeiras Roubin S. Relative performance evaluation of four bleeding risk scores in atrial fibrillation patients. What does the new DOAC score provide? Int J Cardiol. 2024;407:132018. ↗